Clinical Trials Directory

Trials / Completed

CompletedNCT01335230

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Exploring the Role of Gut-associated TH17 in Microbial Translocation in HIV and HCV/HIV Co-infected Patients

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.

Detailed description

Objective 1: Characterization of the Gut Associated Lymphocytes (GALT) in HIV, HCV and coinfected patients regarding the role of Th17 and cytokine profiles. Hypothesis 1a: HIV and HCV/HIV coinfection is associated with changes in Th17 numbers and functions in GALT. Hypothesis 1b: HIV and HCV/HIV coinfection is associated with changes in cytokine profiles in intestinal mucosa. Objective 2: Identify the relationship between changes in Gut Associated Lymphocytes (GALT) in HIV, HCV and coinfected patients and markers of microbial translocation. Hypothesis 2a: Changes in GALT are associated with increase in microbial translocation in HIV, HCV and coinfected patients.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2011-04-14
Last updated
2015-09-11
Results posted
2014-08-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01335230. Inclusion in this directory is not an endorsement.